Tissue engineering

Cards (8)

  • Current medical practices for replacing defective tissues?
    • Synthetic implants: Poor biocompatibility and Mechanical Failure
    • Transplants: Rejection, Disease transmission, Availability of donor organs, Cost
    • Ultimate Aim Of Tissue Engineering is to solve the problem of availability of donor organs and tissue rejection
  • Issues with current tissue regeneration technique:
    • Difficulties in creating vascularised tissue constructs
    • Insufficient mechanical strength of engineered tissues
    • Replicating cellular organisation in complex tissues
  • Scaffold required properties:
    • Self Supporting
    • Porous
    • Biodegradable
    • Non Toxic
  • Main Components of Tissue Engineering
    1. Cells: taken from patient to culture and seed onto scaffold
    2. Scaffold: Allows cells to survive, communicate and differentiate in 3D whilst directing cell development, nutrient flow and removal of waste metabolites
    3. Cell Signals: macromolecules produced by the cells that Instructs the cells to behave as they should
  • Extra cellular matrix (ECM)
    • The glue that holds all the cells together in the body
    • Made of proteins, mainly collagen
    • Gives structure, allows cells to attach and move products in an out of tissue.
    • Cells they can sense and feel what they’re attached to, and this will direct the cell phenotype.
  • Holoclar
    • Autologous Stem Cell Implant
    • Limbal stem cell deficiency of the corneal epithelium–Burns or trauma
    • Stem cells biopsy taken from eye, and gown into a fibrin scaffold which is implanted back into the patient
    • Patient receiving treatment is also the donor
  • Apligraf:
    • Living bi-layered skin substitute
    1. epidermal layer is formed by human keratinocytes
    2. dermal layer is composed of human fibroblasts in a bovine Type I collagen lattice
    • Manufactured under aseptic conditions from human neonatal male foreskin tissue
    • Indicated for non-infected skin ulcers due to venous insufficiency which have not responded to conventional ulcer therapy.
  • Tissue-engineered product: "cells or tissues that have been subject to substantial manipulation with a view to regenerating, repairing or replacing a human tissue"